How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives
Autor: | Ali, Özden Gür, Topaler, Başak |
---|---|
Zdroj: | The European Journal of Health Economics, 2011 Dec 01. 12(6), 553-562. |
Databáze: | JSTOR Journals |
Externí odkaz: |